CVS HEALTH EQUITY ACTION
DEAD

Serial Number

97208194

Owner

CVS PHARMACY, INC.

Attorney

Erich G. Rhynhart

Filing Date

Jan 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CVS HEALTH EQUITY ACTION Trademark

Serial Number: 97208194

CVS HEALTH EQUITY ACTION is a trademark filed by CVS PHARMACY, INC. on January 7, 2022. The trademark is classified under Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

CVS PHARMACY, INC. (1,097 trademarks)

WOONSOCKET, RI 02895

Entity Type: 03

Trademark Details

Filing Date

January 7, 2022

Registration Date

Not Registered

Published for Opposition

March 14, 2023

Goods & Services

Class 35: Administration of an initiative, namely, promoting public awareness of sickle cell disease, HIV, cardiovascular disease, hypertension, and obesity in underserved populations, to improve health equity; administration of an initiative, namely, promoting public awareness of sickle cell disease, HIV, cardiovascular disease, hypertension, and obesity in underserved populations, to identify and address social determinants of health; providing a health data collection and analysis program, namely, systemization of health data in computer databases to identify members with conditions and behaviors linked to healthcare disparities; business administration of pharmacy benefit management services to improve health outcomes for at-risk members; business administration of pharmacy reimbursement programs and services; pharmaceutical drug utilization review services; analyzing health data in the nature of analyzing and compiling data for business purposes in the fields of medicine and healthcare, namely, collecting, combining, and analyzing prescription claim data from private and public sources, to identify members with conditions and behaviors linked to healthcare disparities

health care services, namely, providing health care programs to improve health equity and identify social determinants of health in the field of sickle cell disease, HIV, cardiovascular disease, hypertension, and obesity

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 11, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 11, 2023 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 9, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 3, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 3, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 3, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 3, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 3, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 29, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 18, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2022 NWOS
NEW APPLICATION ENTERED
Jan 11, 2022 NWAP